Ubiquitylation of the TNFR1 signalling complex (TNF-RSC) controls the activation of RIPK1, a kinase critically involved in mediating multiple TNFα-activated deleterious events. However, the molecular mechanism that coordinates different types of ubiquitylation modification to regulate the activation of RIPK1 kinase remains unclear. Here, we show that ABIN-1/NAF-1, a ubiquitin-binding protein, is recruited rapidly into TNF-RSC in a manner dependent on the Met1-ubiquitylating complex LUBAC to regulate the recruitment of A20 to control Lys63 deubiquitylation of RIPK1. ABIN-1 deficiency reduces the recruitment of A20 and licenses cells to die through necroptosis by promoting Lys63 ubiquitylation and activation of RIPK1 with TNFα stimulation under conditions that would otherwise exclusively activate apoptosis in wild-type cells. Inhibition of RIPK1 kinase and RIPK3 deficiency block the embryonic lethality of Abin-1 -/mice. We propose that ABIN-1 provides a critical link between Met1 ubiquitylation mediated by the LUBAC complex and Lys63 deubiquitylation by phospho-A20 to modulate the activation of RIPK1.
R IPK1 is a critical regulator of necroptosis and apoptosis, two distinct regulated cell death mechanisms that may be activated under alternative conditions when cells are stimulated by TNFα, an important proinflammatory cytokine involved in mediating a multitude of human diseases 1, 2 . Under apoptotic-deficient conditions, however, the kinase activity of RIPK1 is activated to interact with RIPK3 to induce the formation of a RIPK1/RIPK3 complex, known as complex lib or necrosome, which promotes the execution of necroptosis [3] [4] [5] . A20 is an important ubiquitin-editing enzyme involved in regulating RIPK1 ubiquitylation 6 . Activation of RIPK1 has been shown to be critical for major human inflammatory degenerative diseases such multiple sclerosis, Crohn's disease and amyotrophic lateral sclerosis [7] [8] [9] [10] . Human clinical trials on small-molecule inhibitors of RIPK1 are underway in pharmaceutical and biotechnology companies for developing drugs targeting amyotrophic lateral sclerosis, Alzheimer's disease, rheumatoid arthritis and Crohn's disease 11 . On the other hand, inactivation of the TNFAIP3 gene, encoding the A20 protein, is associated with inflammatory diseases including multiple sclerosis, rheumatoid arthritis and Crohn's disease 12, 13 . Understanding the interactive relationship between RIPK1 and A20 may be important for developing effective drugs to treat these conditions. However, the molecular mechanism that regulates the interactionof A20 in TNF-RSC to control the activation of RIPK1 kinase remains unclear.
TNFα stimulation induces the trimerization of TNFR1 to promote the formation of a transient intracellular multi-protein complex, the TNFR1 signalling complex TNF-RSC (also called complex I), which recruits RIPK1 via homotypic interactions of their death domains 14 . TNF-RSC is modified by a complex pattern of ubiquitylation chains with different linkages, including Met1, Lys48 and Lys63 (ref. 15 ). In TNF-RSC, cIAP1/2 mediate Lys63 ubiquitylation of RIPK1 (ref. 16 ), which in turn promotes the recruitment of the linear ubiquitin chain assembly complex (LUBAC), composed of HOIP, HOIL-1 and SHARPIN, and subsequent conjugation of Met1 ubiquitin chains 17 . Deficiency in the LUBAC complex leads to impaired activation of NF-kB and increased sensitivity to cell death in response to TNFα stimulation, which can be inhibited by the RIPK1 inhibitor R-7-Cl-O-Necrostatin-1 (Nec-1s) [17] [18] [19] . Knockdown of HOIL-1 and HOIP leads to a significant reduction in the recruitment of the IKK complex, the kinase critical for the activation of NF-kB. On the other hand, it is not clear how deficiency in LUBAC sensitizes cells to RIPK1-mediated cell death.
ABIN-1 is a ubiquitin-binding protein that can bind to both Lys63 and Met1 ubiquitin chains but not to Lys48 chains 20 . Specific risk haplotypes in the gene Abin-1 (TNFAIP3-interacting protein 1, or Tnip1) are strongly associated with a predisposition for autoimmune inflammatory diseases such as systemic lupus erythematosus and psoriasis 21, 22 . These risk haplotypes produce lower levels of Abin-1 messenger RNA and ABIN-1 protein, suggesting that the susceptibility to autoimmunity is due to their hypomorphic function. Abin-1 -/mice die during late embryogenesis due to fetal liver cell death, anaemia and hypoplasia, which can be blocked by TNFα deficiency 23 .
In this study, we show that ABIN-1 functions as a critical link between Met1/Lys63 ubiquitylation and deubiquitylation of TNF-RSC to control the activation of RIPK1 kinase activity. ABIN-1 deficiency sensitizes cells to necroptosis by promoting the Lys63 ubiq uitylation and activation of RIPK1 following TNFα stimulation. The recruitment of ABIN-1 into TNF-RSC requires the LUBAC complex whereas ABIN-1 deficiency inhibits the association of phospho-A20 with TNF-RSC. Importantly, genetic inactivation of
ABIN-1 regulates RIPK1 activation by linking Met1 ubiquitylation with Lys63 deubiquitylation in TNF-RSC
ABIN-1 deficiency promotes the activation of RIPK1. We next characterized the involvement of the necroptotic machinery in TNFαinduced cell death of ABIN-1-deficient cells. We first examined whether ABIN-1 may regulate RIPK1 activation using anti-phospho-Ser166-RIPK1, a marker for RIPK1 activation 27, 28 . We found that the levels of p-Ser166 RIPK1 were elevated at earlier time points and higher in Abin-1 -/-MEFs than in WT MEFs and in RGC-5 cells with ABIN-1-knockdown treated with TNFα/CHX/zVAD.fmk ( Fig. 2a-c) . Furthermore, increased p-Ser166 RIPK1 was inhibited in the presence of Nec-1s and by the genetic inactivation mutant D138N RIPK1.
Since RIPK1 is an upstream activator of RIPK3 and MLKL, we next tested whether the formation of complex IIb, the complex consisting of RIPK1, RIPK3 and FADD necroptosis 3, 4, 29 , was elevated in Abin-1 -/-MEFs. When MEFs were stimulated by TNFα/CHX/zVAD.fmk, we found that the RIPK1/RIPK3 interaction appeared earlier and at higher levels in Abin-1 -/-MEFs than in WT cells. Furthermore, we detected increased interaction of p-Ser166 RIPK1 with FADD in Abin-1 -/-MEFs stimulated by TNFα/CHX/zVAD compared with that in the WT control ( Fig. 2e ).
When MEFs were stimulated with TNFα/CHX/zVAD.fmk, higher levels of phospho-MLKL, a marker for MLKL activation 30 , were detected in Abin-1 -/-MEFs in WT ( Fig. 2f,g ). Furthermore, we found that when treated with TNFα/zVAD.fmk, Abin-1 -/-MEFs also showed increased p-MLKL and p-Ser166 RIPK1 compared with WT MEFs (Fig. 2h ). Importantly, the formation of complex IIb and p-MLKL in both Abin-1 -/and WT MEFs was effectively blocked by Nec-1s, as well as in Abin-1 -/-; Ripk1 D138N/D138N MEFs ( Fig. 2c-i) . On the basis of these results, we conclude that ABIN-1 deficiency promotes the activation of RIPK1 to mediate necroptosis.
Inhibition of necroptosis prolongs the survival of Abin-1 -/cells with activated caspases.
Nec-1s can inhibit necroptosis of WT MEFs induced by TNFα/CHX/zVAD but not apoptosis induced by TNFα/CHX 19 . Surprisingly, we found that treatment with Nec-1s also reduced the death of Abin-1 -/-MEFs induced by TNFα/CHX in the absence of zVAD.fmk, a condition that normally induces apoptosis independently of RIPK1. Similar data were obtained using both immortalized and primary Abin-1 -/-MEFs ( Fig. 3a-c) . TNFα/CHX-induced death of RGC-5 cells was also sensitized by knockdown of ABIN-1 and inhibited by Nec-1s ( Fig. 3d ).
TNFα stimulation under certain conditions may induce the activation of RIPK1 to mediate apoptosis, termed RIPK1-dependent apoptosis. However, RIPK1-dependent apoptosis induced by TNFα stimulation combined with cIAP1/2 deficiency, TAK1 inhibition or IKKα/IKKβ deficiency cannot be blocked by knockdown of RIPK3 or MLKL [31] [32] [33] ( Supplementary Fig. 2a ). Unexpectedly, we found that the survival of Abin-1 -/-MEFs stimulated by TNFα/CHX was prolonged by knockdown of RIPK3 or MLKL ( Fig. 3e ) and by genetic mutations in Abin-1 -/-; Ripk1 D138N/D138N mutant MEFs or in Abin-1 -/-; Ripk3 -/-MEFs ( Fig. 3f,g) . Thus, blocking key mediators of necroptosis can prolong the survival of TNFα/CHX-treated ABIN-1 -/cells, a condition that normally induces RIPK1-independent apoptosis.
Since TNFα/CHX-induced apoptosis involves the activation of caspases, we next characterized the biochemical evidence for caspase activation in Abin-1 -/cells. Although the binding of RIPK1 with caspase-8 was not different in Abin-1 -/-MEFs stimulated by TNFα/CHX compared with that of WT MEFs ( Supplementary  Fig. 2b ), the stimulation of Abin-1 -/-MEFs treated with TNFα/CHX led to not only earlier and stronger cleavage of PARP-1, caspase-3 and RIPK1, mediated by caspase-8 (ref. 34 ), but also the simultaneous appearance of phosphorylated MLKL, which, as expected, was not detected in Abin-1 +/+ MEFs (Fig. 4a ). In addition, we also detected the formation of complex IIb, defined by the interaction between RIPK1/RIPK3 that is normally found only under necroptotic conditions after inhibition of caspases 35 in Abin-1 -/-MEFs stimulated by TNFα/CHX (Fig. 4b ). The formation of complex IIb and phosphorylation of MLKL induced by TNFα/CHX in Abin-1 -/-MEFs were blocked by Nec-1s and in Abin-1 -/-; Ripk1 D138N/D138N MEFs (Fig. 4c,d ).
We next investigated the effect of inhibiting RIPK1 kinase activity on the hallmarks of caspase activation in Abin-1 -/-MEFs. Interestingly, Nec-1s treatment, genetic inactivation of RIPK1 kinase, and RIPK3 deficiency each blocked MLKL phosphorylation and prolonged the survival of Abin-1 -/-MEFs treated with TNFα/CHX, without affecting caspase-3 activation or cleavage of its substrate, PARP. Thus, the normally pro-apoptotic stimulus TNFα/CHX can activate necroptosis in ABIN-1-deficient cells and, furthermore, inhibition of RIPK1 kinase activity or RIPK3 deficiency can promote their survival without blocking caspase activation. Thus, inhibition of RIPK1 kinase activity and RIPK3 can promote the survival of Abin-1 -/-MEFs stimulated by TNFα/CHX without blocking caspase activation.
Recruitment of ABIN-1 into TNF-RSC is dependent on LUBAC and RIPK1.
We next investigated whether ABIN-1 was recruited into TNF-RSC (complex I) of TNFα-stimulated cells. ABIN-1 was rapidly recruited into TNF-RSC within 5 min of TNFα stimulation ( Fig. 5a ). Although ABIN-1 deficiency had no effect on the recruitment of RIPK1 into TNF-RSC, the high-molecular-weight ubiquitylation of RIPK1 was increased in Abin-1 -/-MEFs. Furthermore, we found that significantly increased phosphorylation of Ser166 RIPK1 was associated with TNF-RSC in Abin-1 -/-MEFs ( Fig. 5b ). Knockdown of ABIN-1 in RGC-5 cells had a similar effect ( Supplementary Fig. 3a ). Inhibition of RIPK1 by Nec-1s blocked the appearance of phospho-Ser166 RIPK1, but had no effect on the high-molecular-weight-ubiquitylated RIPK1 (Fig. 5c ).
Since RIPK1 is known to be predominantly modified by Lys63 ubiquitylation in TNF-RSC 36, 37 , we next examined the impact of ABIN-1 deficiency on RIPK1 Lys63 ubiquitylation using tandem immunoprecipitation. TNF-RSC was first immunoprecipitated in the native condition. The Flag-TNFα immunocomplexes were then dissociated in 6 M urea and a second immunoprecipitation was conducted in the denatured condition using a Lys63 linkage-specific polyubiquitin antibody 37 . The Lys63 ubiquitylation levels of RIPK1 were analysed by western blotting for RIPK1. This experiment revealed that Lys63 ubiquitylation of TNFR1-associated RIPK1 was increased in Abin-1 -/-MEFs compared with that of WT (Fig. 5d ). The increased Lys63 ubiquitylation levels of RIPK1 in Abin-1 -/-MEFs were further confirmed by directly immunoprecipitating Lys63-ubiquitylated proteins in cells lysed in 6 M urea and followed by western blotting for RIPK1 ( Supplementary Fig. 3b ). In addition, we also analysed the Lys63-ubiquitylation pattern of RIPK1 in complex IIb; consistently, increased Lys63 ubiquitylation of RIPK1 in Abin-1 -/-MEFs stimulated by TCZ was detected before the activation of RIPK1, detected by anti-p-Ser166 RIPK1 ( Supplementary Fig. 3c ).
Since ABIN-1 deficiency had no effect on the recruitment of HOIP and SHARPIN ( Supplementary Fig. 3d ), the key components of the LUBAC complex that mediates Met1 ubiquitylation of TNF-RSC, we next investigated whether the recruitment of ABIN-1 into TNF-RSC was affected by LUBAC. We found that the recruitment of ABIN-1 was blocked in Hoip -/-MEFs ( Fig. 5e ), as reported for A20 (ref. 38 ) ( Fig. 5e ). Furthermore, SM-164 treatment, which eliminates cIAP1/2, also reduced the recruitment of ABIN-1 into TNF-RSC ( Fig. 5f ). Thus, the recruitment of ABIN-1 depends on the presence and/or output of the LUBAC complex and cIAP1/2 in TNF-RSC.
ABIN-1 stabilizes the recruitment of phospho-A20 in TNF-RSC.
As HOIP-deficient cells are unable to recruit ABIN-1 or A20 to TNF-RSC, we next investigated whether there was a relationship Abin-1 +/+ D138N MEFs were treated with TNFα/CHX/zVAD.fmk (TCZ) in the presence or absence of Nec-1s for the indicated periods of time. The cell lysates were probed with anti-RIPK1(p-Ser166) or anti-total RIPK1. c, RGC-5 cells were transfected with the indicated siRNA or non-targeting control (NC) siRNA for 48 h and treated with TNFα/CHX/zVAD.fmk for the indicated time periods in the presence or absence of Nec-1s as shown. The cell lysates were analysed by anti-p-RIPK1(p-Ser166), anti-RIPK1, anti-p-MLKL and anti-MLKL. d,e, Complex lib in WT (Abin-1 +/+ ) or Abin-1 -/-MEFs treated with TNFα/CHX/zVAD.fmk was immunoprecipitated using anti-RIPK3 (d) or anti-FADD (e). The immunocomplexes were analysed by western blotting using antibodies against RIPK1 and RIPK3 (d) or anti-p-Ser166-RIPK1, anti-total RIPK1, anti-p-MLKL and anti-MLKL (e). f, WT (Abin-1 +/+ ) and Abin-1 -/-MEFs were treated with TNFα/CHX/zVAD.fmk in the presence or absence of Nec-1s for the indicated periods of time. The cell lysates were probed with anti-p-MLKL and anti-MLKL. g, WT (Abin-1 +/+ ; Ripk1 +/+ ), Abin-1 -/-; Ripk1 +/+ , Abin-1 +/+ ; Ripk1 D138N and Abin-1 -/-; Ripk1 D138N MEFs as indicated were treated with TNFα/CHX/zVAD.fmk. The cell lysates were analysed by western blotting using anti-p-MLKL and anti-MLKL. h, WT (Abin-1 +/+ ) and Abin-1 -/-MEFs were treated with TNFα/zVAD in the presence or absence of Nec-1s as indicated. The cell lysates were analysed by western blotting using anti-p-MLKL, anti-MLKL and anti-p-RIPK1(p-Ser166). i, WT (Abin-1 +/+ ; Ripk1 +/+ ), Abin-1 -/-; Ripk1 +/+ , Abin-1 +/+ ; Ripk1 D138N and Abin-1 -/-; Ripk1 D138N MEFs as indicated were treated with TNFα/CHX/zVAD.fmk. Anti-RIPK3 was used to immunoprecipitate complex IIb and immunocom plexes were analysed by western blotting using the indicated antibodies. β-Actin was a loading control. TNFα (T): 10 ng ml −1 ; cycloheximide (CHX or C): 1 μg ml −1 ; zVAD.fmk (Z): 20 μM; Nec-1s: 10 μM. Experiments were repeated independently with similar results twice (e) or at least three times (a-d,f-i). Unprocessed original scans of blots are shown in Supplementary Fig. 7 .
between the recruitment of these two proteins. Like that of ABIN-1-deficient cells, the p-Ser166 RIPK1 in A20 -/-MEFs stimulated by TNFα/CHX/zVAD was enhanced compared with that of WT cells ( Supplementary Fig. 3e ). Thus, we considered the possibility that ABIN-1 might control the activation of RIPK1 by regulating the recruitment of A20 to TNF-RSC. While the expression of A20 was largely normal in Abin-1 -/-MEFs, the levels of A20 in TNF-RSC were significantly reduced by ABIN-1 deficiency (Fig. 6a) .
TNFα stimulation has also been shown to lead to phosphorylation of A20 and CYLD by IKK complex as well as activation of p38 (refs. [39] [40] [41] [42] ). While the phosphorylation of A20, CYLD and p38 induced by TNFα was largely unaffected by ABIN-1 deficiency ( Supplementary Fig. 4a ), using an anti-phospho-Ser381 A20 anti-body 40 , the recruitment of phospho-A20 to TNF-RSC was significantly reduced in Abin-1 -/-MEFs compared with that of the WT (Fig. 6a ). On the other hand, the recruitment of IKKβ and Supplementary Fig. 1c . e, WT and Abin-1 -/-MEFs were transfected with siRNA for RIPK3 or MLKL, or control non-targeting (NC) siRNA, to knock down RIPK3 and MLKL. The knockdown control is shown in Fig. 1d . f,g, MEFs with the indicated genotypes were treated with TNFα alone, CHX alone and TNFα/CHX as indicated. Depicted P values were calculated for Abin-1 -/and Abin-1 -/-Ripk1 D138N (f) or Abin-1 -/and Abin-1 -/-Ripk3 -/-MEFs (g) treated with TC. Cell death was measured by ToxiLight (a-e) or CellTiter-Glo (f,g) assays. TNFα (T): 10 ng ml −1 ; cycloheximide (CHX or C): 1 μg m l −1 (a,c,e-g) or 10 μ ml −1 (b,d); Nec-1s: 10 μM. The graphs depict the mean (± s.e.m.) of n = 4 independent biological experiments. P values were calculated by two-tailed Student's t-test (*P < 0.05, **P < 0.01, ***P < 0.001). Source data together with precise P values can be found in Supplementary Table 2. NEMO to TNF-RSC in Abin-1 -/-MEFs was not altered (Fig. 6a,b) . Importantly, the increased RIPK1 ubiquitylation in the TNF-RSC of Abin-1 -/-MEFs was not affected by the treatment with Nec-1s ( Fig. 6b) . Thus, regulating the recruitment of phosphorylated A20 into TNF-RSC by ABIN-1 affects the ubiquitylation of RIPK1.
We next asked whether phosphorylation of A20 played a role in its recruitment into TNF-RSC. Using A20 -/-MEFs complemented with WT or S381A A20 mutant, we found that the stimulation of TNFα induced the recruitment of WT, but not the S381A A20 mutant, into TNF-RSC ( Fig. 6c ). Furthermore, the recruitment of the S381D mutant in the WT cells was highly effective but remained deficient in Abin-1 -/-MEFs (Fig. 6d ). To directly test whether ABIN-1 might be able to interact with phosphorylated A20, we immunoprecipitated ABIN-1 from TNFα-stimulated cells and found that A20 interacting with ABIN-1 was effectively phosphorylated and, furthermore, the binding of ABIN-1 with the S381A mutant was significantly reduced (Fig. 6e,f) , suggesting that a critical function of Ser381 phosphorylation of A20 is to promote its recruitment into TNF-RSC by interacting with ABIN-1. 
Abin-1 +/+
Abin-1 -/- Supplementary Fig. 7 .
Fig. 4 | Inhibition of necroptosis prolongs cell survival but has no effect on caspase activation in Abin-1 -/cells treated with
Truncated ABIN-1 (amino acids 1-420) was unable to bind to A20 ( Supplementary Fig. 4b) 43 . Consistently, unlike full-length ABIN-1, truncated ABIN-1 (amino acids 1-420) was unable to suppress the enhanced sensitivity of Abin-1 -/-MEFs to necroptosis induced by TNFα/CHX/zVAD ( Supplementary Fig. 4c ). Furthermore, the truncated ABIN-1 (amino acids 1-420) could not be recruited into Supplementary Fig. 7 . complex I; nor could the expression of truncated ABIN-1 rescue the ability of Abin-1 -/-MEFs to recruit A20 ( Supplementary Fig. 4d ). Thus, the domain of ABIN-1 that is required for binding with A20 is also required for the recruitment of A20 and ABIN-1 into complex I. Taking these results together, we conclude that the recruitment of phospho-A20 by ABIN-1 into TNF-RSC may play a critical role in regulating Lys63 ubiquitylation and activation of RIPK1.
Blocking necroptosis rescues the embryonic lethality of Abin-1 -/mice. Since Abin-1 -/deficiency in mice leads to TNFα-mediated embryonic lethality after post-coital day E18.5 (ref. 23 ), we considered the possibility that necroptosis might contribute to the embryonic lethality of Abin-1 -deficient mice. We generated Abin-1 -/-; Ripk3 -/double-knockout (DKO) mice and Abin-1 -/-; Ripk1 D138N/D138N mice. As expected, we were unable to obtain viable Abin-1 -/-; Ripk3 +/+ or Abin-1 -/-; Ripk1 +/+ mice. Consistent with the activation of both apoptosis and necroptosis following loss of ABIN-1, Abin-1 -/-E16.5 embryonic tissues exhibited hallmarks of apoptosis, including the cleavage of caspase-3 and PARP-1, and necroptosis, including the increased levels of RIPK1, RIPK3 and MLKL in the Fig. 6 | ABIN-1 is important for the recruitment of p-A20 into TNF-RSC. a, WT (Abin-1 +/+ ) and Abin-1 -/-MEFs were stimulated by Flag-TNFα (100 ng ml −1 ) for the indicated periods of time. TNF-RSC (Complex I) was immunoprecipitated using anti-FLAG resin, and the recruitment of A20, p-A20(p-S381) and IKKβ was analysed using the indicated antibodies by western blotting analysis. b, WT (Abin-1 +/+ ) and Abin-1 -/-MEFs were stimulated by Flag-TNFα (100 ng ml −1 ) for the indicated periods of time in the presence or absence of Nec-1s as indicated, and TNF-RSC (Complex I) was immunoprecipitated using anti-FLAG resin and analysed using the indicated antibodies. β-Actin is a loading control. c, A20 -/-MEFs complemented with FLAG-A20 WT (FLAG-A20) or FLAG-A20-S381A mutant (S381A) were stimulated by TNFα (100 ng ml −1 ) for the indicated periods of time. Complex I was immunoprecipitated by anti-TNFR1 antibody from the lysates and analysed by anti-A20 and anti-TNFR1. d, TNF-RSC in WT (Abin-1 +/+ ) and Abin-1 -/-MEFs expressing FLAG-A20-S381D mutant was analysed by anti-TNFR1. e, WT (Abin-1 +/+ ) MEFs were stimulated by TNFα (100 ng ml −1 ) for the indicated periods of time. ABIN-1 was immunoprecipitated from cell lysates using anti-ABIN-1 and the immunocomplex was analysed by anti-p-A20(p-S381) and anti-A20. f, A20 -/-MEFs complemented with FLAG-A20 WT (FLAG-A20) or FLAG-A20-S381A mutant (S381A) as in c were treated with TNFα for the indicated periods of time. The cell lysates were analysed by anti-ABIN-1 immunoprecipitation followed by western blotting using anti-A20 and anti-ABIN-1. β-Actin is a loading control. Experiments were repeated independently with similar results twice (c,d,f) or at least three times (a,b,e). Unprocessed original scans of blots are shown in Supplementary Fig. 7. insoluble fraction, which is known to occur when cells undergo necroptosis 27, 35 -as well as the phosphorylation of MLKL (Fig. 7a) . Interestingly, these biochemical hallmarks of both apoptosis and necroptosis were completely absent in E16.5 Abin-1 -/-; Ripk3 -/-DKO and Abin-1 -/-; Ripk1 D138N/D138N embryos (Fig. 7b ). Furthermore, Abin-1 -/-; Ripk3 -/-DKO mice and Abin-1 -/-; Ripk1 D138N/D138N mice were born at expected Mendelian ratios ( Supplementary Table 1 ) and were indistinguishable from their WT littermates when examined at ~8 weeks of age ( Supplementary Fig. 5 ). Furthermore, histolopathological analysis and TUNEL staining of embryonic E18 livers revealed massive necrosis in Abin-1 -/mice that was suppressed by the RIPK1 D138N mutation (Fig. 7c-e ). Thus, inhibiting necroptosis and apoptosis effectively rescues the embryonic lethality and allows the normal development of Abin-1 -/mice.
Discussion
Understanding the molecular mechanism that regulates the dynamics of ubiquitylation-deubiquitylation of TNF-RSC has been a critical goal of TNFα research. We show here that the dominant function of ABIN-1 in TNF-RSC is to connect the Met1-ubiquitylating Abin -1 -/embryos. a,b The embryos of the indicated genotypes at ~E16.5 were isolated and dissected. Tissue lysates from the head (a) and the rest of the body (a,b) were subject to analysis by western blotting using the indicated antibodies. Unprocessed original scans of blots are shown in Supplementary Fig. 7 . c, Gross appearance of E17. complex LUBAC in TNF-RSC with the recruitment of A20, a deubiquitylating enzyme that modulates Lys63 ubiquitylation of RIPK1 ( Supplementary Fig. 6 ). Phosphorylation of A20 has been shown to promote its deubiquitylation activity 36, 40 ; however, the mechanism by which TNF-RSC recruits this important modulator was unclear. The recruitment of ABIN-1 into TNF-RSC requires the LUBAC complex, whose recruitment depends on cIAP1/2, which provides Lys63, as well as Lys11, ubiquitylation of TNF-RSC 17, 44 . The ability of ABIN-1 to bind to both Lys63 and Met1 ubiquitin chains 20 fits perfectly with its role as a modulator of TNF-RSC ubiquitylation to connect the TNFR1 complex decorated with both Lys63 and Met1 ubiquitylations with the phospho-A20 deubiquitylating enzyme to modulate the activation of RIPK1. Thus, ABIN-1 is a key missing piece in connecting Met1/Lys63-ubiquitylated TNFR1 with A20-mediated deubiquitylation. A20 was identified as a regulator of NF-κ B 45, 46 . Recently, it was reported that A20 deficiency sensitized cells to necroptosis 47 . Thus, the inability to effectively recruit A20 provides an important mechanism for the increased sensitivity of ABIN-1-deficient cells and Abin-1 -/mice to both apoptosis and necroptosis. These results also suggest that a critical mechanism mediated by the NF-κ B pathway in suppressing the activation of RIPK1 and cell death is through upregulation of A20 expression and phosphorylation of A20 medi-ated by the activated IKK complex to promote its recruitment into TNF-RSC by interacting with ABIN-1 that in turn modulates the ubiquitylation pattern of RIPK1 to prevent its activation. Importantly, since ABIN-1 deficiency has no effect on the activation of NF-κ B mediated by TNF, these results suggest that the dominant functions of ABIN-1 and A20 in the TNF-RSC are to control the activation of RIPK1.
Fig. 7 | The presence of hallmarks of both apoptosis and necroptosis in Abin
LUBAC-mediated Met1 ubiquitylation is important for efficient recruitment of NEMO and activation of the NEMO/IKK/ IKK (NEMO/IKK) complex to promote the downstream NF-kB pathway 17 . Our results suggest that mediating the recruitment of ABIN-1 might be an additional role of LUBAC-mediated Met1 ubiquitylation in TNF-RSC, independent of its role in regulating NF-κ B activation. On the other hand, inactivation of LUBAC not only blocks the recruitment of ABIN-1, but also inhibits the phosphorylation of A20 mediated by the IKK complex. Thus, a common consequence of deficiency in either LUBAC or ABIN-1 is to lead to an imbalanced ubiquitylation pattern that includes dysregulated Lys63 ubiquitylation of RIPK1. Since deficiencies in HOIP, ABIN-1 and A20 all promote the activation of RIPK1, we propose that an imbalanced ubiquitylation of RIPK1 that includes increased Lys63 ubiquitylation and/or decreased Met1 ubiquitylation of RIPK1 may be critical in mediating its activation to promote cell death. Future studies are needed to identify the sites of RIPK1 modification by different E3 ubiquitin ligases, characterize the types ofubiquitin linkages and elucidate their functional significances in regulating the activation of RIPK1.
Our study described here demonstrates a unique paradigm that ABIN-1 deficiency sensitizes cells to both apoptosis and necroptosis. Furthermore, blocking RIPK1 or RIPK3 is sufficient to offer complete protection against embryonic lethality of Abin-1 -/mice. Necroptosis maybe activated in ABIN-1-deficient cells stimulated by TNFα/CHX, which is a classical pro-apoptotic stimulus in WT cells. Furthermore, blocking necroptosis might allow cell survival with activated caspases. The ability of cells to tolerate certain levels of activated caspases is consistent with the increasing acknowledgement of caspases mediating non-apoptotic functions, such as cytokine production, cell migration and neuronal function 48 .
Our results suggest that a key function of ABIN-1 during embryonic development is to suppress cell death by regulating TNFR1 signalling. Since suppression of necroptosis by RIPK1 D138N mutation or RIPK3 deficiency is sufficient to protect embryonic survival of Abin-1 -/mice, our results also suggest that the activation of necroptosis is highly detrimental to embryonic development. Since the activation of necroptosis mediates the lethality of mice with mutations in multiple genes such as caspase-8, FADD or the non-catalytically active caspase-8 homologue cFLIP and ABIN-1 during embryonic development [49] [50] [51] [52] , we propose that necroptosis may be evolved as a key quality-control mechanism during embryogenesis to ensure the development of normal vertebrate animals.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41556-017-0003-1.
Statistics and reproducibility. Each individual experiment was repeated independently with similar results at least three times, except the experiments shown in Figs. 2e, 4d, 5d, 6c ,d,f and 7a,b and Supplementary Figs. 2b and 3c , which were performed twice. Statistical analysis was performed using Microsoft Excel 2011.
Prism 7 software was used to generate graphs. Statistical significance was evaluated by using two-tailed Student's t-test. Differences were considered statistically significant if P < 0.05(*); P < 0.01(**) or P < 0.001(***). Data are expressed as the mean ± standard error of the mean (s.e.m.). Exact P values for each experiment (where applicable) can be found in Supplementary Table 2 .
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A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
